WELLESLEY, Mass., Aug. 09, 2017 (GLOBE NEWSWIRE) --
Rising demand for immunoglobulins is the main driver of the global market for blood plasma products, which has the potential to reach $23 billion by 2021. In a new report, BCC Research studies the industry’s prospects through different perspectives, including product applications, end user consumption, and global market analysis.
Deficiencies in a blood plasma component can result in the onset of disease, which has led to acceleration in both basic and targeted R&D in this area. Blood plasma is a part of effective treatment for several chronic and life-threatening diseases such as hemophilia, leukemia, and immunodeficiency disorders. Blood plasma products have proven to be a boon for patients suffering from such diseases. From approximately $16.8 billion in 2016 sales, product launches and improvements in existing technologies will expand this industry through 2021, according to the report Global Markets for Blood Plasma Products.
The United States leads the market due to the surging demand for hemophilia therapies. The Asia-Pacific region, led by China, held the second largest market share in 2016.
Research Highlights
- Plasma products are key in the burgeoning field of immunotherapy. Immunoglobulins play a crucial role in the treatment of immunocompromised patients.
- The majority of markets in the Asia-Pacific and Rest of the World regions are untapped and thus provide opportunities for manufacturers of blood plasma products to expand their businesses.
- In addition, China has adopted several plasma fractionation technologies to ensure sufficient blood plasma supply throughout Asia.
Concerns Include High Costs, Safety
Immunodeficiency is a significant concern in various regions of the world and is expected to drive growth in the global market for blood plasma products. Two major restraining factors are the high costs associated with these therapies and the threat of transmission of blood-borne diseases. Ensuring safety as well as efficacy during blood donations and transfusions will be paramount.
About BCC Research
BCC Research is a publisher of market research reports that provide organizations with intelligence to drive smart business decisions. By partnering with industry experts worldwide, BCC Research provides unbiased measurements and assessments of global markets covering major industrial and technology sectors, including emerging markets. For more information about BCC Research, please visit bccresearch.com. Follow BCC Research on Twitter at @BCCResearch.